UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 176

Sortiert nach

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

The New England journal of medicine, 2018-12, Vol.379 (23), p.2220-2229

2018

Volltextzugriff (PDF)

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2011-08, Vol.29 (22), p.2965-2971

2011

Volltextzugriff (PDF)

Ceritinib in second and further lines of therapy in advanced ALK mutant adenocarcinoma

Journal of thoracic disease, 2016-07, Vol.8 (7), p.E584-E585

Losonczy, György

2016

Volltextzugriff (PDF)

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD

Respiratory research, 2019-07, Vol.20 (1), p.156-10, Article 156

2019

Volltextzugriff (PDF)

The link between the sphingolipid rheostat and obstructive sleep apnea

Scientific reports, 2023-05, Vol.13 (1), p.7675-7675, Article 7675

2023

Volltextzugriff (PDF)

Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses

ERJ open research, 2021-01, Vol.7 (1), p.543

2021

Volltextzugriff (PDF)

Central and peripheral airway nitric oxide in patients with stable and exacerbated chronic obstructive pulmonary disease

Journal of breath research, 2018-05, Vol.12 (3), p.036017-036017

2018

Volltextzugriff (PDF)

Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report

JTO clinical and research reports, 2022-06, Vol.3 (6), p.100330-100330, Article 100330

2022

Volltextzugriff (PDF)

Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

BMC pulmonary medicine, 2011-07, Vol.11 (1), p.40-40, Article 40

2011

Volltextzugriff (PDF)

Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy

PloS one, 2013-04, Vol.8 (4), p.e60697-e60697

2013

Volltextzugriff (PDF)

Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure

The European respiratory journal, 2017-02, Vol.49 (2), p.1601270-1601270

2017

Volltextzugriff (PDF)

P192: Endothelial Dysfunction, Arterial Stiffness in Lung Transplanted Individuals

Artery research, 2017-12, Vol.20 (1), p.109-109

2017

Volltextzugriff (PDF)

Density of tumor-infiltrating NK and Treg cells is associated with 5 years progression-free and overall survival in resected lung adenocarcinoma

Lung cancer (Amsterdam, Netherlands), 2024-06, Vol.192, p.107824-107824, Article 107824

2024

Volltextzugriff (PDF)

Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study

Lung cancer (Amsterdam, Netherlands), 2020-11, Vol.149, p.46-52

2020

Volltextzugriff (PDF)

Resveratrol induces mitochondrial biogenesis in endothelial cells

American journal of physiology. Heart and circulatory physiology, 2009-07, Vol.297 (1), p.H13-H20

2009

Volltextzugriff (PDF)

Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide

Lung cancer (Amsterdam, Netherlands), 2023-12, Vol.186, p.107418-107418, Article 107418

2023

Volltextzugriff (PDF)

Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer

The oncologist (Dayton, Ohio), 2018-06, Vol.23 (6), p.654-e58

2018

Volltextzugriff (PDF)

A suitable protocol for measuring alveolar nitric oxide in asthma with differing severity to assess peripheral airways inflammation

The Journal of asthma, 2019-06, Vol.56 (6), p.584-593

2019

Volltextzugriff (PDF)

Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy

PloS one, 2014-04, Vol.9 (4), p.e94678-e94678

2014

Volltextzugriff (PDF)

Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: Role of circulating factors and SIRT1

Mechanisms of ageing and development, 2009-08, Vol.130 (8), p.518-527

2009

Volltextzugriff (PDF)

Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia

American journal of physiology. Heart and circulatory physiology, 2011-04, Vol.300 (4), p.H1133-H1140

2011

Volltextzugriff (PDF)

Resveratrol Prevents Monocrotaline-Induced Pulmonary Hypertension in Rats

Hypertension (Dallas, Tex. 1979), 2009-09, Vol.54 (3), p.668-675

2009

Volltextzugriff (PDF)

1 – 25 von 176

Suche als RSS-Feed

Aktive Filter

ThemaImmunology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(144)

Publikationsform

Artikel
(176)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer

Randomized Phase III Placebo-Controlled Trial of Carboplatin and Paclitaxel With or Without the Vascular Disrupting Agent Vadimezan (ASA404) in Advanced Non–Small-Cell Lung Cancer

Ceritinib in second and further lines of therapy in advanced ALK mutant adenocarcinoma

Dysregulation of the endothelial nitric oxide pathway is associated with airway inflammation in COPD

The link between the sphingolipid rheostat and obstructive sleep apnea

Blood eosinophils on hospital admission for COPD exacerbation do not predict the recurrence of moderate and severe relapses

Central and peripheral airway nitric oxide in patients with stable and exacerbated chronic obstructive pulmonary disease

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line therapy in patients with stage IV squamous non-small-cell lung cancer (SQUIRE): an open-label, randomised, controlled phase 3 trial

Impact of Brain Metastases on Treatment Patterns and Outcomes With First-Line Durvalumab Plus Platinum-Etoposide in Extensive-Stage SCLC (CASPIAN): A Brief Report

Asthma control in patients receiving inhaled corticosteroid and long-acting beta2-agonist fixed combinations. A real-life study comparing dry powder inhalers and a pressurized metered dose inhaler extrafine formulation

Relationship of circulating soluble urokinase plasminogen activator receptor (suPAR) levels to disease control in asthma and asthmatic pregnancy

Necitumumab plus pemetrexed and cisplatin as first-line therapy in patients with stage IV non-squamous non-small-cell lung cancer (INSPIRE): an open-label, randomised, controlled phase 3 study

Airway dynamics in COPD patients by within-breath impedance tracking: effects of continuous positive airway pressure

P192: Endothelial Dysfunction, Arterial Stiffness in Lung Transplanted Individuals

Density of tumor-infiltrating NK and Treg cells is associated with 5 years progression-free and overall survival in resected lung adenocarcinoma

Patient-reported outcomes with first-line durvalumab plus platinum-etoposide versus platinum-etoposide in extensive-stage small-cell lung cancer (CASPIAN): a randomized, controlled, open-label, phase III study

Resveratrol induces mitochondrial biogenesis in endothelial cells

TG4010 immunotherapy and first-line chemotherapy for advanced non-small-cell lung cancer (TIME): results from the phase 2b part of a randomised, double-blind, placebo-controlled, phase 2b/3 trial

Clinical and molecular characterization of long-term survivors with extensive-stage small cell lung cancer treated with first-line atezolizumab plus carboplatin and etoposide

Randomized Phase II Trial of Parsatuzumab (Anti‐EGFL7) or Placebo in Combination with Carboplatin, Paclitaxel, and Bevacizumab for First‐Line Nonsquamous Non‐Small Cell Lung Cancer

A suitable protocol for measuring alveolar nitric oxide in asthma with differing severity to assess peripheral airways inflammation

Relationship of circulating hyaluronic acid levels to disease control in asthma and asthmatic pregnancy

Anti-oxidative and anti-inflammatory vasoprotective effects of caloric restriction in aging: Role of circulating factors and SIRT1

Adaptive induction of NF-E2-related factor-2-driven antioxidant genes in endothelial cells in response to hyperglycemia

Resveratrol Prevents Monocrotaline-Induced Pulmonary Hypertension in Rats

Aktive Filter

Suchergebnisse filtern